TY - JOUR
T1 - Successful Use of Octreotide Therapy for Refractory Levofloxacin-Induced Hypoglycemia
T2 - A Case Report and Literature Review
AU - Watson, Matthew R.
AU - Ward, Ceressa T.
AU - Prabhakar, Amit
AU - Fiza, Babar
AU - Moll, Vanessa
N1 - Publisher Copyright:
© 2019 Matthew R. Watson et al.
PY - 2019
Y1 - 2019
N2 - Fluoroquinolones are commonly prescribed antimicrobials that have been implicated in alterations of glucose metabolism. We report a case of refractory fluoroquinolone-induced hypoglycemia in a patient with type-2 diabetes mellitus on glipizide that was successfully treated with octreotide. A patient was admitted with hypoglycemia after having been initiated on levofloxacin therapy. Despite treating the hypoglycemia supportively with multiple boluses of 25 g of dextrose, a continuous dextrose infusion, and glucagon, the patient experienced repeated episodes of rebound hypoglycemia. The persistent hypoglycemia was eventually reversed with the administration of subcutaneous octreotide. Clinicians should be cognizant of this adverse effect of fluoroquinolones, as well as predisposing risk factors, and consider octreotide as an adjunctive therapy for refractory hypoglycemia cases.
AB - Fluoroquinolones are commonly prescribed antimicrobials that have been implicated in alterations of glucose metabolism. We report a case of refractory fluoroquinolone-induced hypoglycemia in a patient with type-2 diabetes mellitus on glipizide that was successfully treated with octreotide. A patient was admitted with hypoglycemia after having been initiated on levofloxacin therapy. Despite treating the hypoglycemia supportively with multiple boluses of 25 g of dextrose, a continuous dextrose infusion, and glucagon, the patient experienced repeated episodes of rebound hypoglycemia. The persistent hypoglycemia was eventually reversed with the administration of subcutaneous octreotide. Clinicians should be cognizant of this adverse effect of fluoroquinolones, as well as predisposing risk factors, and consider octreotide as an adjunctive therapy for refractory hypoglycemia cases.
UR - http://www.scopus.com/inward/record.url?scp=85100838597&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100838597&partnerID=8YFLogxK
U2 - 10.1155/2019/3560608
DO - 10.1155/2019/3560608
M3 - Article
AN - SCOPUS:85100838597
SN - 2090-6420
VL - 2019
JO - Case Reports in Critical Care
JF - Case Reports in Critical Care
M1 - 3560608
ER -